Levetiracetam Sandoz 100 Mg / 1 Ml, Oral Solution (Levetiracetam)

Levetiracetam exerts its antiepileptic effect by binding to the synaptic vesicle protein SV2A, which plays a key role in neurotransmitter release. This binding modulates vesicle exocytosis, reduces excessive neuronal firing, and stabilizes synaptic transmission, thereby lowering the likelihood of seizure initiation and propagation throughout the brain.

The appropriate dose of Levetiracetam Sandoz Oral Solution is individualized and determined by the prescribing clinician based on the patient’s age, weight, renal function, seizure type, and response to therapy. The prescriber will calculate the exact millilitre volume needed to deliver the required milligram dose.

The safety of levetiracetam during pregnancy and lactation has not been definitively established. It is classified as pregnancy category unknown, so clinicians must weigh potential benefits against possible risks. Women who are pregnant, planning pregnancy, or breastfeeding should discuss treatment options with their healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide. After the request, the sales team will verify trade or institutional credentials, then provide pricing, availability, shipping details (including any required cold‑chain handling) and import documentation.

Levetiracetam offers a broad spectrum of seizure control with a relatively favorable interaction profile compared with many enzyme‑inducing antiepileptics such as carbamazepine or phenytoin. It does not require routine serum level monitoring and is generally well tolerated, though individual response and side‑effect patterns vary, making it a common alternative to older agents like valproate or phenobarbital.

Levetiracetam Sandoz Oral Solution should be stored at room temperature, below 25 °C, in its original container. Protect the bottle from excessive moisture, direct sunlight, and extreme temperature fluctuations. Do not freeze the solution, and keep the cap tightly closed when not in use.

The solution is taken orally, measured with a calibrated dosing device such as an oral syringe or calibrated cup. It may be administered with or without food, according to the prescriber’s instructions. Patients should follow the exact volume prescribed and avoid altering the concentration by mixing with other liquids unless advised.

Serious risks include severe allergic reactions (e.g., anaphylaxis), significant mood changes such as depression or suicidal thoughts, and rare dermatologic emergencies like Stevens‑Johnson syndrome. Patients should be monitored closely for any new or worsening psychiatric symptoms, skin rash, or signs of hypersensitivity, and seek immediate medical attention if these occur.

Levetiracetam is contraindicated in individuals with known hypersensitivity to levetiracetam or any of the formulation’s excipients. Caution is also advised for patients with severe renal impairment who may require dose adjustment, and for those with a history of serious psychiatric disorders, as they may be at higher risk for mood‑related adverse events.